C16 Biosciences is a biotechnology company based in New York, New York, specializing in innovative solutions for decarbonizing the consumer products supply chain. Located in the heart of the city at 619 W 54th St, the company focuses on leveraging cutting-edge biotechnological processes to create sustainable alternatives to traditional petrochemical products. By applying advanced fermentation techniques, C16 Biosciences aims to reduce the environmental footprint associated with manufacturing consumer goods.
Operating within the dynamic biotechnology sector, C16 Biosciences combines scientific research with practical applications to develop bio-based ingredients that can replace fossil fuel-derived components. Their approach supports industries seeking to transition towards greener production methods without compromising performance or scalability. The company’s work contributes to a broader movement within biotechnology to address climate change through innovative materials science and sustainable bioprocessing.
C16 Biosciences’ location in New York City provides access to a rich ecosystem of research institutions, industry partners, and a diverse talent pool. This setting fosters collaboration and accelerates the development of biotechnological innovations designed to meet the growing demand for environmentally responsible consumer products. The company’s focus on sustainability and biotechnology positions it as a key player in the evolving landscape of green manufacturing.
With a commitment to advancing bio-based technologies, C16 Biosciences continues to explore new frontiers in biotechnology that aim to replace traditional supply chain inputs with more sustainable options. Their work exemplifies the potential of biotechnology companies in urban centers like New York to contribute to a more sustainable future for consumer products across various industries.
